Clearpoint Neuro Inc expected to post a loss of 31 cents a share - Earnings Preview

Clearpoint Neuro

26/10/2026 21:17

Clearpoint Neuro Inc CLPT.OQ CLPT.O is expected to  show a rise in quarterly revenue when it reports  results on October 28 for the period ending September 30 2026
The Solana Beach California-based  company is expected to report a 38.8% increase in revenue to $12.3 million from $8.86 million a year ago, according to the mean estimate from 2 analysts, based on LSEG data.
​LSEG's mean analyst estimate for Clearpoint Neuro Inc is for a loss of 31 cents per share. 
The current average analyst rating on the shares is "strong buy" and the breakdown of recommendations is 2 "strong buy" or "buy," no "hold" and no "sell" or "strong sell."  
The mean earnings estimate of analysts was unchanged in the last three months. ​
Wall Street's median 12-month price target for Clearpoint Neuro Inc is $23.50, about 157.1% above its last closing price of $9.14
This summary was machine generated October 26 at 21:17 GMT.  All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)